SweetValueLab
Write for us

Dow vs LyondellBasell DOW vs LYB

Dow and LyondellBasell on one sheet: valuation multiples, growth, margins, debt, dividends and returns, each section labelled with the period it covers, from the companies' filings. Add or remove a stock above the sheet; the link holds the set.

Compare other stocks
DOWLYB

What differs most

generated from the numbers below
  • EV / EBITDA: LyondellBasell 17.7×, Dow 11.3×.
  • Price / sales: LyondellBasell 0.7×, Dow 0.6×.
  • One-year price return: LyondellBasell +41.5%, Dow +37.0%.

Price return

2025-10-26 → 2026-10-26
DOW+37.0%
LYB+41.5%
-50%0%50%100%2025-10-242026-04-272026-10-26
Prices at the close on 2026-10-26
DOW
Dow
$33.99

Profile

latest
Sector
Basic Materials
Basic Materials
Industry
Chemicals
Chemicals - Specialty
Market value
$24.55B
$21.76B
Enterprise value
$39.32B
$33.35B
Employees
32,800
18,970
Revenue per employee (TTM)
$1.3M
$1.6M

Our models

nightlythe valuation on each stock's page
Price vs model
13% undervalued vs model
100% overvalued vs model
Model range
$14.11–106
$12.49–54.96
Models in the headline
1
1
FCF growth priced in, at a 10% return
—
38.5%
Every model, its assumptions and its range: DOW valuation · LYB valuation. The growth priced in, at any return: DOW reverse DCF · LYB reverse DCF.

Trading

close 2026-10-26
Last close
$33.99
$67.35
52-week high
$41.87
$82.38
52-week low
$20.95
$42.28
Price vs 52-week high
−18.8%
−18.2%
Price vs 52-week low
+62.2%
+59.3%
Average daily volume / shares
1.4%
1.3%
Beta
0.41
0.35

Returns

to 2026-10-26
1 month
+21.3%
+15.8%
3 months
+13.9%
+11.7%
6 months
−12.1%
−3.6%
Year to date
+45.4%
+55.5%
1 year
+37.0%
+41.5%
1 year, dividends added
+42.6%
+48.7%
2 years
−31.6%
−23.0%

Valuation

DOW price × TTM to Sep 2026 · LYB price × TTM to Jun 2026
P/E (TTM)
n/m
n/m
P/E on consensus EPS (next FY)
14.0×
7.3×
Price / sales
0.6×
0.7×
EV / sales
0.9×
1.1×
EV / EBITDA
11.3×
17.7×
Price / book
1.5×
2.0×
Price / free cash flow (FY)
n/m
56.7×
Free-cash-flow yield (FY)
−5.9%
1.8%

Growth

TTM and FY2025
Revenue growth (TTM)
—
—
Revenue growth, consensus next FY
+10.0%
+10.4%
Revenue, 3-year CAGR
−11.1%
−15.8%
Revenue, 5-year CAGR
0.7%
1.7%
EPS growth (TTM)
—
—
EPS growth, consensus next FY
—
—
EPS, 3-year CAGR
—
—
Free cash flow, 3-year CAGR
—
−55.1%
Diluted shares, 3-year change
−1.9%
−1.8%

Profitability

DOW TTM to Sep 2026 · LYB TTM to Jun 2026
Gross margin (FY)†
6.0%
9.0%
Operating margin
3.6%
3.2%
EBITDA margin
8.2%
6.0%
Net margin
−1.9%
−1.1%
Free-cash-flow margin (FY)
−3.6%
1.3%
Return on equity
−5.0%
−3.3%
Return on assets
−1.3%
−1.0%
Asset turnover
0.70
0.90
† Gross margin (FY): As filed. Companies draw the cost-of-revenue line in different places, so gross margins of two companies in one industry can differ for that reason alone; operating margin does not depend on where the line is drawn.

Balance sheet

DOW MRQ Sep 2026 · LYB MRQ Jun 2026
Cash
$4.14B
$2.63B
Total debt
$18.91B
$14.22B
Net debt
$14.77B
$11.59B
Debt / equity
1.2×
1.3×
Net debt / EBITDA (TTM)
4.2×
6.1×
Interest coverage (FY)
0.3×
-0.6×
Current ratio (FY)
1.97
1.77

Dividends

trailing 12 months
Dividend yield
4.1%
5.1%
Dividends per share
$1.40
$3.44
Payout ratio (of TTM EPS)
—
—
Dividend per share, 5-year CAGR
−12.9%
−4.6%
Frequency
Quarterly
Quarterly

Ownership and activity

last 90 days · latest 13F
Tracked superinvestors holding (13F)
4
3
Insider open-market buys (Form 4)
$0
$0
Insider sales (Form 4)
$0
$0
Analyst upgrades
1
1
Analyst downgrades
1
1

Statements

DOW income TTM to Sep 2026 · cash flow FY2025 · LYB income TTM to Jun 2026 · cash flow FY2025
Revenue
$42.61B
$31.19B
EBITDA
$3.48B
$1.89B
Operating income
$1.55B
$1.01B
Net income
−$809.0M
−$348.0M
EPS (diluted)
−$1.28
−$1.11
Operating cash flow
$1.03B
$2.26B
Capital expenditure
−$2.48B
−$1.88B
Free cash flow
−$1.45B
$384.0M
Dividends paid
$1.49B
$1.76B

Keep comparing

the matchups people search for

Statements, prices, dividends and consensus estimates from Financial Modeling Prep; insider trades from Form 4 and holdings from 13F. Refreshed nightly. A comparison of filed numbers, not a recommendation to buy, sell or hold any security.